SRRA Insider Trading - Sierra Oncology Inc

Akcje insidera

7 464 864 shares

Wynik sentymentu insiderów

Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.

Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, które zawierają listę firm o największej akumulacji informacji poufnych.

Zobacz akcje o najwyższym rankingu

Ocena sentymentu kadry kierowniczej

Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.

Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.

Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, zobaczysz listę firm o najwyższym sentymencie insiderów.

Zobacz akcje o najwyższym rankingu

Kluczowe wskaźniki insider

Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.

Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.

Liczba netto zakupów dokonanych przez insiderów (ranking)

N/A

Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).

Procent akcji kupowanych przez insiderów (ranking)

N/A

Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.

Wykres handlu insider

Poniższy wykres przedstawia Sierra Oncology Inc transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.

Lista insiderów i wskaźniki rentowności

Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.

See our leaderboard of most profitable insider traders.

Insider	Średni zysk (%)	Posiadane Akcje	Podział korygujący

Report errors via our new Insider Auditing Tool

Śledź historię zakupów insiderów — analiza zysków krótkoterminowych

W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w SRRA / Sierra Oncology Inc. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji	Insider	Zgłoszone Akcje	Zgłoszona Cena	Skorygowane Akcje	Skorygowana Cena	Podstawa kalkulacji kosztów	Dni do Maks	Cena Maks	Maks Zysk ($)	Maks zwrot (%)
2022-02-02	Longitude Capital Partners III, LLC	175 000	27,0000	175 000	27,0000	4 725 000	148	54.9900	4 898 250	103,67
2022-01-31	Vivo Opportunity, LLC	800 000	27,0000	800 000	27,0000	21 600 000
2022-01-31	Abingworth LLP	150 000	27,0000	150 000	27,0000	4 050 000
2021-11-24	Collard Craig A	7 899	23,0850	7 899	23,0850	182 348
2021-11-23	Collard Craig A	5 601	22,9450	5 601	22,9450	128 515
2021-05-19	DILLY STEPHEN GEORGE	5 000	17,8300	5 000	17,8300	89 150
2020-08-18	Klencke Barbara	5 950	12,2201	5 950	12,2201	72 710
2020-08-18	Klencke Barbara	3 325	12,2519	3 325	12,2519	40 738
2019-08-23	Klencke Barbara	108 000	0,4387	2 700	17,5480	47 380

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

SRRA / Sierra Oncology Inc Insider Trades

Śledź historię sprzedaży insider — analiza strat krótkoterminowych

W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w SRRA / Sierra Oncology Inc. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji	Insider	Zgłoszone Akcje	Zgłoszona Cena	Skorygowane Akcje	Skorygowana Cena	Podstawa kalkulacji kosztów	Dni do Min	Cena Min	Maksymalna strata Uniknięto ($)	Maksymalna strata Uniknięto (%)
Nie są znane żadne nieplanowane transakcje na otwartym rynku dla tego insidera

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

Historia transakcji

Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.

Plik Data	Data transakcji	Formularz	Wtajemniczony	Serce	Nazwa papieru wartościowego	Kod	Bezpośredni	Cena wykonania	Cena jednostki	Zmieniono jednostki	Zmieniona wartość (1 tys.)	Pozostałe opcje	Pozostałe akcje
2022-07-01	2022-07-01	4	Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P.	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-431 947	-23 757		0
2022-07-01	2022-07-01	4	Vivo Opportunity, LLC By: Vivo Opportunity Fund Holdings, L.P.	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-2 735 853	-150 472		0
2022-07-01	2022-07-01	4	Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-161 712	-8 894		0
2022-07-01	2022-07-01	4	ORBIMED ADVISORS LLC See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-226 704	-12 469		0
2022-07-01	2022-07-01	4	ORBIMED ADVISORS LLC See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-226 704	-12 469		0
2022-07-01	2022-07-01	4	ORBIMED ADVISORS LLC See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-1 511 362	-83 125		0
2022-07-01	2022-07-01	4	Ashiya Mona See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-226 704	-12 469		0
2022-07-01	2022-07-01	4	Ashiya Mona See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-226 704	-12 469		0
2022-07-01	2022-07-01	4	Ashiya Mona See footnotes	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-1 511 362	-83 125		0
2022-07-01	2022-07-01	4	Aggarwal Gaurav By: Vivo Opportunity Fund Holdings, L.P.	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-2 735 853	-150 472		0
2022-07-01	2022-07-01	4	Klencke Barbara By spouse	SRRA	Common Stock	D - Sale to Issuer	I		55,0000	-5 000	-275		0
2022-07-01	2022-07-01	4	Klencke Barbara	SRRA	Common Stock	D - Sale to Issuer	D		55,0000	-10 000	-550		0
2022-07-01	2022-07-01	4	Sinclair Andrew See footnotes	SRRA	Common Stock, $0.001 par value	D - Sale to Issuer	I		55,0000	-1 314 127	-72 277		0
2022-07-01	2022-07-01	4	Allen Andrew R	SRRA	Common Stock	D - Sale to Issuer	D		55,0000	-1 650	-91		0
2022-07-01	2022-07-01	4	Collard Craig A	SRRA	Common Stock	D - Sale to Issuer	D		55,0000	-13 500	-742		0
2022-07-01	2022-07-01	4	DILLY STEPHEN GEORGE	SRRA	Common Stock	D - Sale to Issuer	D		55,0000	-5 000	-275		0
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			840			8 015
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			252			2 404
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			588			5 611
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			7 175			7 175
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			2 152			2 152
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			5 023			5 023
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			-1 964 771			0
2022-04-29	2022-04-27	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	J - Other	I			-175 000			0
2022-04-07	2022-04-06	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		6 347		0
2022-04-07	2022-04-06	4	Turner William D.	SRRA	Common Stock	S - Sale	D		37,2474	-6 347	-236		0
2022-04-07	2022-04-06	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	6 347	76		6 347
2022-04-07	2022-04-05	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		100		0
2022-04-07	2022-04-05	4	Turner William D.	SRRA	Common Stock	S - Sale	D		37,0900	-100	-4		0
2022-04-07	2022-04-05	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	100	1		100
2022-04-04	2022-04-04	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	M - Exercise	D	13,04		2 000		0
2022-04-04	2022-04-04	4	Thomson Mary Christina	SRRA	Common Stock	S - Sale	D		35,1384	-2 000	-70		0
2022-04-04	2022-04-04	4	Thomson Mary Christina	SRRA	Common Stock	M - Exercise	D		13,0400	2 000	26		2 000
2022-03-22	2022-03-18	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		100		0
2022-03-22	2022-03-18	4	Turner William D.	SRRA	Common Stock	S - Sale	D		37,0500	-100	-4		0
2022-03-22	2022-03-18	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	100	1		100
2022-03-17	2022-03-17	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		3 453		0
2022-03-17	2022-03-17	4	Turner William D.	SRRA	Common Stock	S - Sale	D		37,0558	-3 453	-128		0
2022-03-17	2022-03-17	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	3 453	42		3 453
2022-03-14	2022-03-14	4	DILLY STEPHEN GEORGE	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		165 000		165 000
2022-03-14	2022-03-14	4	Jagpal Sukhi	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		50 000		50 000
2022-03-14	2022-03-14	4	Klencke Barbara	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		50 000		50 000
2022-03-14	2022-03-14	4	Norrett Kevin	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		35 000		35 000
2022-03-14	2022-03-14	4	Turner William D.	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		35 000		35 000
2022-03-14	2022-03-14	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	A - Award	D	31,54		35 000		35 000
2022-03-04	2022-03-04	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	M - Exercise	D	13,04		2 000		0
2022-03-04	2022-03-04	4	Thomson Mary Christina	SRRA	Common Stock	S - Sale	D		30,5981	-2 000	-61		0
2022-03-04	2022-03-04	4	Thomson Mary Christina	SRRA	Common Stock	M - Exercise	D		13,0400	2 000	26		2 000
2022-02-08	2022-02-07	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		10 000		0
2022-02-08	2022-02-07	4	Turner William D.	SRRA	Common Stock	S - Sale	D		32,3225	-10 000	-323		0
2022-02-08	2022-02-07	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	10 000	120		10 000
2022-02-04	2022-02-04	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	M - Exercise	D	13,04		2 000		0
2022-02-04	2022-02-04	4	Thomson Mary Christina	SRRA	Common Stock	S - Sale	D		29,7800	-2 000	-60		0
2022-02-04	2022-02-04	4	Thomson Mary Christina	SRRA	Common Stock	M - Exercise	D		13,0400	2 000	26		2 000
2022-02-02	2022-02-02	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	P - Purchase	I		27,0000	175 000	4 725		175 000
2022-02-02	2022-02-02	4	Richardson Joshua	SRRA	Common Stock	P - Purchase	I		27,0000	175 000	4 725		175 000
2022-02-02		3	Longitude Prime Fund, L.P.	SRRA	Common Stock		I						175 000
2022-02-01	2022-01-31	4	Sinclair Andrew See footnotes	SRRA	Common Stock, $0.001 par value	P - Purchase	I		27,0000	150 000	4 050		1 314 127
2022-02-01	2022-01-28	4	Sinclair Andrew See footnotes	SRRA	Series B Warrants (right to buy)	X - Other	I	13,20		-287 471		0
2022-02-01	2022-01-28	4	Sinclair Andrew See footnotes	SRRA	Common Stock, $0.001 par value	X - Other	I		13,2000	287 471	3 795		1 164 127
2022-02-01	2022-01-31	4	Abingworth LLP	SRRA	Common Stock, $0.001 par value	P - Purchase	I		27,0000	150 000	4 050		1 314 127
2022-02-01	2022-01-28	4	Abingworth LLP	SRRA	Series B Warrants (right to buy)	X - Other	I	13,20		-287 471		0
2022-02-01	2022-01-28	4	Abingworth LLP	SRRA	Common Stock, $0.001 par value	X - Other	I		13,2000	287 471	3 795		1 164 127
2022-01-31	2022-01-31	4	Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P.	SRRA	Common Stock	P - Purchase	I		27,0000	800 000	21 600		2 735 853
2022-01-31	2022-01-31	4	Aggarwal Gaurav By Vivo Opportunity Fund, L.P.	SRRA	Common Stock	P - Purchase	I		27,0000	800 000	21 600		2 735 853
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes	SRRA	Series B Warrants	X - Other	I	13,20		-56 244		0
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes	SRRA	Series B Warrants	X - Other	I	13,20		-56 244		0
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes	SRRA	Series B Warrants	X - Other	I	13,20		-374 962		0
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes (4),	SRRA	Common Stock	X - Other	I		13,2000	56 244	742		226 704
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes	SRRA	Common Stock	X - Other	I		13,2000	56 244	742		226 704
2022-01-28	2022-01-26	4	Ashiya Mona See footnotes (4),	SRRA	Common Stock	X - Other	I		13,2000	374 962	4 949		1 511 362
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC	SRRA	Series B Warrants	X - Other	I	13,20		-56 244		0
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC	SRRA	Series B Warrants	X - Other	I	13,20		-56 244		0
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC	SRRA	Series B Warrants	X - Other	I	13,20		-374 962		0
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC	SRRA	Common Stock	X - Other	I		13,2000	56 244	742		226 704
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC See footnote (4),	SRRA	Common Stock	X - Other	I		13,2000	56 244	742		226 704
2022-01-28	2022-01-26	4	ORBIMED ADVISORS LLC See footnote (4),	SRRA	Common Stock	X - Other	I		13,2000	374 962	4 949		1 511 362
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P.	SRRA	Series B Warrant (Right to Purchase )	X - Other	I	13,20	13,2000	-324 740	-4 287	0
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P.	SRRA	Series B Warrant (Right to Purchase )	X - Other	I	13,20	13,2000	-1 455 384	-19 211	0
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Series B Warrant (Right to Purchase )	X - Other	I	13,20	13,2000	-75 749	-1 000	0
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P.	SRRA	Common Stock	X - Other	I		13,2000	107 164	1 415		431 947
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P.	SRRA	Common Stock	X - Other	I		13,2000	480 277	6 340		1 935 853
2022-01-28	2022-01-26	4	Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock	X - Other	I		13,2000	24 996	330		161 712
2022-01-28	2022-01-26	4	Aggarwal Gaurav By Vivo Opportunity Fund, L.P.	SRRA	Series B Warrant (Right to Purchase)	X - Other	I	13,20	13,2000	-1 455 384	-19 211	0
2022-01-28	2022-01-26	4	Aggarwal Gaurav By Vivo Opportunity Fund, L.P.	SRRA	Common Stock	X - Other	I		13,2000	480 277	6 340		1 935 853
2022-01-28	2022-01-28	4	Klencke Barbara	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-28	4	Kowalski Mark	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-28	4	Norrett Kevin	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-28	4	DILLY STEPHEN GEORGE	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		65 000		65 000
2022-01-28	2022-01-28	4	Jagpal Sukhi	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-28	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-26	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	M - Exercise	D	13,04		2 000		0
2022-01-28	2022-01-26	4	Thomson Mary Christina	SRRA	Common Stock	S - Sale	D		29,0000	-2 000	-58		0
2022-01-28	2022-01-26	4	Thomson Mary Christina	SRRA	Common Stock	M - Exercise	D		13,0400	2 000	26		2 000
2022-01-28	2022-01-28	4	Turner William D.	SRRA	Stock Option (Right to Buy)	A - Award	D	12,15		12 250		12 250
2022-01-28	2022-01-26	4	Turner William D.	SRRA	Stock Option (Right to Buy)	M - Exercise	D	12,05		5 000		0
2022-01-28	2022-01-26	4	Turner William D.	SRRA	Common Stock	S - Sale	D		27,0500	-5 000	-135		0
2022-01-28	2022-01-26	4	Turner William D.	SRRA	Common Stock	M - Exercise	D		12,0500	5 000	60		5 000
2022-01-27	2022-01-25	4	Longitude Capital Partners III, LLC	SRRA	Series B Warrants	X - Other	I	13,20	13,2000	-1 477 125	-19 498	0
2022-01-27	2022-01-25	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	X - Other	I		13,2000	487 451	6 434		1 964 771
2022-01-27	2022-01-25	4	Richardson Joshua By Longitude Venture Partners III, L.P.	SRRA	Series B Warrants	X - Other	I	13,20	13,2000	-1 477 125	-19 498	0
2022-01-27	2022-01-25	4	Richardson Joshua By Longitude Venture Partners III, L.P.	SRRA	Common Stock	X - Other	I		13,2000	487 451	6 434		1 964 771
2021-11-24	2021-11-24	4	Collard Craig A	SRRA	Common Stock	P - Purchase	D		23,0850	7 899	182		13 500
2021-11-24	2021-11-23	4	Collard Craig A	SRRA	Common Stock	P - Purchase	D		22,9450	5 601	129		5 601
2021-11-05		3	Abingworth LLP	SRRA	Common Stock, $0.001 par value		I						878 656
2021-06-28	2021-03-15	4	Thomson Mary Christina	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		12 900		12 900
2021-06-28	2020-07-28	4	Thomson Mary Christina	SRRA	Stock option (right to buy)	A - Award	D	13,04		100 000		100 000
2021-06-09	2021-06-08	4	Cooper Jeffrey H	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Collard Craig A	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Pelzer Robert	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Ashiya Mona	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Allen Andrew R	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Aggarwal Gaurav	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Sinclair Andrew	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-09	2021-06-08	4	Richardson Joshua	SRRA	Stock Option (Right To Buy)	A - Award	D	18,11		6 000		6 000
2021-06-04	2021-06-02	4	Oliger Christy J.	SRRA	Stock Option (right to buy)	A - Award	D	17,76		18 000		18 000
2021-06-04	2021-06-02	4	Erbez Georgia	SRRA	Stock Option (right to buy)	A - Award	D	17,76		18 000		18 000
2021-05-20	2021-05-19	4	DILLY STEPHEN GEORGE	SRRA	Common Stock	P - Purchase	D		17,8300	5 000	89		5 000
2021-03-17	2021-03-15	4	Turner William D.	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		12 300		12 300
2021-03-17	2021-03-15	4	Thomson Christina	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		12 900		12 900
2021-03-17	2021-03-15	4	Norrett Kevin	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		11 700		11 700
2021-03-17	2021-03-15	4	Kowalski Mark	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		30 000		30 000
2021-03-17	2021-03-15	4	Jagpal Sukhi	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		30 000		30 000
2021-03-17	2021-03-15	4	Klencke Barbara	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		30 000		30 000
2021-03-17	2021-03-15	4	DILLY STEPHEN GEORGE	SRRA	Stock Option (Right to Buy)	A - Award	D	16,73		92 000		92 000
2020-08-18	2020-08-18	4	Klencke Barbara By spouse	SRRA	Common Stock	P - Purchase	I		12,2519	3 325	41		5 000
2020-08-18	2020-08-18	4	Klencke Barbara	SRRA	Common Stock	P - Purchase	D		12,2201	5 950	73		10 000
2020-08-12	2020-08-12	4	Jagpal Sukhi	SRRA	Stock Option (right to buy)	A - Award	D	12,15		5 887		5 887
2020-08-12	2020-08-12	4	Kowalski Mark	SRRA	Stock Option (right to buy)	A - Award	D	12,15		24 970		24 970
2020-08-11	2020-08-10	4	Norrett Kevin	SRRA	Stock option (right to buy)	A - Award	D	12,05		100 000		100 000
2020-08-06	2020-08-04	4	Turner William D.	SRRA	Stock option (right to buy)	A - Award	D	12,05		100 000		100 000
2020-07-29	2020-07-28	4	Thomson Christina	SRRA	Stock option (right to buy)	A - Award	D	13,04		100 000		100 000
2020-06-10	2020-06-09	4	Aggarwal Gaurav	SRRA	Stock Option (right to buy)	A - Award	D	13,98		6 874		6 874
2020-06-10	2020-06-09	4	Allen Andrew R	SRRA	Stock Option (right to buy)	A - Award	D	13,98		12 030		12 030
2020-06-10	2020-06-09	4	Ashiya Mona	SRRA	Stock Option (right to buy)	A - Award	D	13,98		6 874		6 874
2020-06-10	2020-06-09	4	Cooper Jeffrey H	SRRA	Stock Option (right to buy)	A - Award	D	13,98		18 061		18 061
2020-06-10	2020-06-09	4	Pelzer Robert	SRRA	Stock Option (right to buy)	A - Award	D	13,98		16 686		16 686
2020-06-10	2020-06-09	4	Richardson Joshua	SRRA	Stock Option (right to buy)	A - Award	D	13,98		6 874		6 874
2020-06-10	2020-06-09	4	Sinclair Andrew	SRRA	Stock Option (right to buy	A - Award	D	13,98		6 874		6 874
2020-06-02	2020-06-01	4	DILLY STEPHEN GEORGE	SRRA	Stock Option (right to buy)	A - Award	D	14,03		520 000		520 000
2020-05-29	2020-05-28	4	Collard Craig A	SRRA	Stock Option (right to buy)	A - Award	D	13,88		10 000		10 000
2020-02-27	2020-02-25	4	Glover Nicholas	SRRA	Stock Option (right to buy)	A - Award	D	13,31		359 158		359 158
2020-02-27	2020-02-25	4	Jagpal Sukhi	SRRA	Stock Option (right to buy)	A - Award	D	13,31		94 113		94 113
2020-02-27	2020-02-25	4	Klencke Barbara	SRRA	Stock Option (right to buy)	A - Award	D	13,31		167 091		167 091
2020-02-27	2020-02-25	4	Kowalski Mark	SRRA	Stock Option (right to buy)	A - Award	D	13,31		75 030		75 030
2020-02-03	2020-01-29	4/A	Sinclair Andrew See footnotes	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-11 500		0
2020-02-03	2020-01-29	4/A	Sinclair Andrew See footnotes	SRRA	Common Stock	C - Conversion	I			871 240			876 656
2020-01-31	2020-01-29	4	ORBIMED ADVISORS LLC See footnotes	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 500		0
2020-01-31	2020-01-29	4	ORBIMED ADVISORS LLC See footnotes	SRRA	Common Stock	C - Conversion	I			1 477 320			1 477 320
2020-01-31	2020-01-29	4	Aggarwal Gaurav By Vivo Opportunity Fund, LP	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 213		0
2020-01-31	2020-01-29	4	Aggarwal Gaurav By Vivo Opportunity Fund, LP	SRRA	Common Stock	C - Conversion	I			1 455 576			1 455 576
2020-01-31	2020-01-29	4	Ashiya Mona See footnotes	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 500		0
2020-01-31	2020-01-29	4	Ashiya Mona See footnotes	SRRA	Common Stock	C - Conversion	I			1 477 320			1 477 320
2020-01-31	2020-01-29	4	Richardson Joshua By Longitude Venture Partners III, L.P.	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 500		0
2020-01-31	2020-01-29	4	Richardson Joshua By Longitude Venture Partners III, L.P.	SRRA	Common Stock	C - Conversion	I			1 477 320			1 477 320
2020-01-31	2020-01-29	4	Longitude Capital Partners III, LLC	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 500		0
2020-01-31	2020-01-29	4	Longitude Capital Partners III, LLC	SRRA	Common Stock	C - Conversion	I			1 477 320			1 477 320
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P.	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-4 287		0
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P.	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-19 213		0
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-1 000		0
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P.	SRRA	Common Stock	C - Conversion	I			324 783			324 783
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P.	SRRA	Common Stock	C - Conversion	I			1 455 576			1 455 576
2020-01-31	2020-01-29	4	Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock	C - Conversion	I			75 759			136 715
2020-01-31	2020-01-29	4	Sinclair Andrew See footnotes	SRRA	Series A Convertible Voting Preferred Stock	C - Conversion	I			-11 500		0
2020-01-31	2020-01-29	4	Sinclair Andrew See footnotes	SRRA	Common Stock	C - Conversion	I			871 125			876 542
2019-12-03	2019-11-29	4	Sinclair Andrew	SRRA	Stock Option (right to buy)	A - Award	D	0,35		60 000		60 000
2019-12-03	2019-11-29	4	Aggarwal Gaurav	SRRA	Stock Option (Right to Buy)	A - Award	D	0,35		60 000		60 000
2019-12-03	2019-11-29	4	Ashiya Mona	SRRA	Stock Option (Right to Buy)	A - Award	D	0,35		60 000		60 000
2019-12-03	2019-11-29	4	Richardson Joshua	SRRA	Stock Option (Right to Buy)	A - Award	D	0,35		60 000		60 000
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-12-02		3	Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.	SRRA	Common Stock		I						4 876 540
2019-11-26		3	Sinclair Andrew See Footnotes	SRRA	Common Stock, $0.001 par value		I						433 334
2019-11-26		3	Sinclair Andrew See Footnotes	SRRA	Common Stock, $0.001 par value		I						433 334
2019-11-26		3	Sinclair Andrew See Footnotes	SRRA	Common Stock, $0.001 par value		I						433 334
2019-08-26	2019-08-23	4	Klencke Barbara	SRRA	Common Stock	P - Purchase	D		0,4387	108 000	47		162 000
2019-08-26	2019-08-22	4	Klencke Barbara	SRRA	Common Stock	P - Purchase	D		0,4499	54 000	24		54 000
2019-08-26	2019-08-22	4	Klencke Barbara By spouse	SRRA	Common Stock	P - Purchase	I		0,4323	67 000	29		67 000
2019-06-12	2019-06-11	4	Cooper Jeffrey H	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	ESTES DANIEL	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	Nguyen Tran	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	ONETTO NICOLE	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	Parfet Donald R	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	Pelzer Robert	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-06-12	2019-06-11	4	Allen Andrew R	SRRA	Stock Option (right to buy)	A - Award	D	0,66		30 000		30 000
2019-03-05	2019-03-04	4	Glover Nicholas	SRRA	Stock Option (right to buy)	A - Award	D	1,96		607 500		607 500
2019-03-05	2019-03-04	4	Hassig Christian	SRRA	Stock Option (right to buy)	A - Award	D	1,96		155 000		155 000
2019-03-05	2019-03-04	4	Jagpal Sukhi	SRRA	Stock Option (right to buy)	A - Award	D	1,96		200 000		200 000
2019-03-05	2019-03-04	4	Klencke Barbara	SRRA	Stock Option (right to buy)	A - Award	D	1,96		200 000		200 000
2019-03-05	2019-03-04	4	Kowalski Mark	SRRA	Stock Option (right to buy)	A - Award	D	1,96		200 000		200 000
2018-12-11	2018-12-10	4	Allen Andrew R	SRRA	Common Stock	P - Purchase	D		1,6400	66 000	108		66 000
2018-06-14	2018-06-12	4	Pelzer Robert	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	ESTES DANIEL	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	Allen Andrew R	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	Cooper Jeffrey H	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	Nguyen Tran	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	ONETTO NICOLE	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-06-14	2018-06-12	4	Parfet Donald R	SRRA	Stock Option (right to buy)	A - Award	D	3,27		25 000		25 000
2018-03-07	2018-03-06	4	Glover Nicholas	SRRA	Stock Option (right to buy)	A - Award	D	2,36		562 780		562 780
2018-03-07	2018-03-06	4	Hassig Christian	SRRA	Stock Option (right to buy)	A - Award	D	2,36		205 180		205 180
2018-03-07	2018-03-06	4	Jagpal Sukhi	SRRA	Stock Option (right to buy)	A - Award	D	2,36		180 360		180 360
2018-03-07	2018-03-06	4	Klencke Barbara	SRRA	Stock Option (right to buy)	A - Award	D	2,36		180 360		180 360
2018-03-07	2018-03-06	4	Kowalski Mark	SRRA	Stock Option (right to buy)	A - Award	D	2,36		155 000		155 000
2018-03-07	2018-03-06	4	You Angie	SRRA	Stock Option (right to buy)	A - Award	D	2,36		180 360		180 360
2018-01-08	2018-01-04	4	Parfet Donald R	SRRA	Common Stock	J - Other	D			1 380			77 235
2018-01-08	2018-01-04	4	Parfet Donald R Apjohn Ventures, LLC	SRRA	Common Stock	J - Other	I			-2 760			0
2018-01-08	2018-01-04	4	Parfet Donald R Apjohn Ventures, LLC	SRRA	Common Stock	J - Other	I			1 068			2 760
2018-01-08	2018-01-04	4	Parfet Donald R Apjohn Ventures, LLC	SRRA	Common Stock	J - Other	I			1 692			1 692
2018-01-08	2018-01-04	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	SRRA	Common Stock	J - Other	I			3 383			390 913
2017-11-13	2017-11-10	4	Allen Andrew R	SRRA	Stock Option (Right to Buy)	A - Award	D	1,92		50 000		50 000
2017-10-25		3	Allen Andrew R	SRRA	No securities beneficially owned.		D						0
2017-06-14	2017-06-13	4	Cooper Jeffrey H	SRRA	Stock Option (right to buy)	A - Award	D	1,13		25 000		25 000
2017-06-14	2017-06-13	4	Nguyen Tran	SRRA	Stock Option (right to buy)	A - Award	D	1,13		25 000		25 000
2017-06-14	2017-06-13	4	ONETTO NICOLE	SRRA	Stock Option (right to buy)	A - Award	D	1,13		25 000		25 000
2017-06-14	2017-06-13	4	Parfet Donald R	SRRA	Stock Option (right to buy)	A - Award	D	1,13		25 000		25 000
2017-06-14	2017-06-13	4	Pelzer Robert	SRRA	Stock Option (right to buy)	A - Award	D	1,13		25 000		25 000
2017-05-30	2017-05-25	4	ESTES DANIEL	SRRA	Stock Option (Right to Buy)	A - Award	D	1,20		50 000		50 000
2017-04-11		3	ESTES DANIEL	SRRA	No securities beneficially owned		D						0
2017-03-09	2017-03-08	4	You Angie	SRRA	Common Stock	P - Purchase	D		1,4300	30 000	43		133 252
2017-03-08	2017-03-06	4	You Angie	SRRA	Stock Option (right to buy)	A - Award	D	1,45		70 000		70 000
2017-03-08	2017-03-06	4	Jagpal Sukhi	SRRA	Stock Option (right to buy)	A - Award	D	1,45		70 000		70 000
2017-03-08	2017-03-06	4	Klencke Barbara	SRRA	Stock Option (right to buy)	A - Award	D	1,45		70 000		70 000
2017-03-08	2017-03-06	4	Glover Nicholas	SRRA	Stock Option (right to buy)	A - Award	D	1,45		195 000		195 000
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						14 038 047
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-24		3	Heron Patrick J	SRRA	Common Stock		D						10 298 316
2017-02-16	2017-02-14	4	Topper James N By Frazier Life Sciences VIII, L.P.	SRRA	Common Stock	P - Purchase	I		1,3500	5 925 926	8 000		5 925 926
2017-01-04		3	Kowalski Mark	DNAI	No securities beneficially held		D						0
2017-01-04	2017-01-03	4	Kowalski Mark	DNAI	Stock Option (right to buy Class A Common Stock)	A - Award	D	1,54		300 000		300 000
2016-11-10	2016-11-08	4	Parfet Donald R	DNAI	Common Stock	J - Other	D			2 403			75 855
2016-11-10	2016-11-08	4	Parfet Donald R Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			-4 806			0
2016-11-10	2016-11-08	4	Parfet Donald R Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			1 423			4 806
2016-11-10	2016-11-08	4	Parfet Donald R Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			3 383			3 383
2016-11-10	2016-11-08	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	J - Other	I			6 767			387 530
2016-10-04	2016-09-30	4	Jagpal Sukhi	DNAI	Stock Option (right to buy)	A - Award	D	1,82		168 000		168 000
2016-10-04	2016-09-30	4	Glover Nicholas	DNAI	Stock Option (right to buy)	A - Award	D	1,82		500 000		500 000
2016-10-04	2016-09-30	4	Klencke Barbara	DNAI	Stock Option (right to buy)	A - Award	D	1,82		456 000		456 000
2016-10-04	2016-09-30	4	You Angie	DNAI	Stock Option (right to buy)	A - Award	D	1,82		200 000		200 000
2016-09-30	2016-09-29	4	Parfet Donald R	DNAI	Common Stock	J - Other	D			1 202			73 452
2016-09-30	2016-09-29	4	Parfet Donald R By Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			-2 403			0
2016-09-30	2016-09-29	4	Parfet Donald R By Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			711			2 403
2016-09-30	2016-09-29	4	Parfet Donald R By Apjohn Ventures, LLC	DNAI	Common Stock	J - Other	I			1 692			1 692
2016-09-30	2016-09-29	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	J - Other	I			3 384			380 763
2016-06-20	2016-06-16	4	ONETTO NICOLE	DNAI	Stock Option (right to buy)	A - Award	D	2,06		38 835		38 835
2016-06-20	2016-06-16	4	Pelzer Robert	DNAI	Stock Option (right to buy)	A - Award	D	2,06		38 835		38 835
2016-06-20	2016-06-16	4	Parfet Donald R	DNAI	Stock Option (right to buy)	A - Award	D	2,06		38 835		38 835
2016-06-20	2016-06-16	4	Topper James N	DNAI	Stock Option (right to buy)	A - Award	D	2,06		38 835		38 835
2016-06-13	2016-06-09	4	Cooper Jeffrey H	DNAI	Stock Option (right to buy)	A - Award	D	2,06		77 670		77 670
2016-06-13	2016-06-09	4	Nguyen Tran	DNAI	Stock Option (right to buy)	A - Award	D	2,06		77 670		77 670
2016-05-17	2016-05-13	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	J - Other	I			3 204			377 379
2016-03-24		3	Nguyen Tran	DNAI	No securities beneficially held		D						0
2016-03-24		3	Cooper Jeffrey H	DNAI	No securities beneficially held		D						0
2016-03-24	2016-03-22	4	Chapman Wendy	DNAI	Stock Option (right to buy)	M - Exercise	D	0,97		-3 000		76 248
2016-03-24	2016-03-22	4	Chapman Wendy	DNAI	Common Stock	S - Sale	D		7,0078	-3 000	-21		0
2016-03-24	2016-03-22	4	Chapman Wendy	DNAI	Common Stock	M - Exercise	D		0,9690	3 000	3		3 000
2016-03-10	2016-03-08	4	Messmann Richard A	DNAI	Stock Option (right to buy)	A - Award	D	6,58		25 000		25 000
2016-03-10	2016-03-08	4	Lovejoy Chandra D	DNAI	Stock Option (right to buy)	A - Award	D	6,58		31 000		31 000
2016-03-10	2016-03-08	4	Jagpal Sukhi	DNAI	Stock Option (right to buy)	A - Award	D	6,58		48 750		48 750
2016-03-10	2016-03-08	4	Glover Nicholas	DNAI	Stock Option (right to buy)	A - Award	D	6,58		161 250		161 250
2016-03-10	2016-03-08	4	Klencke Barbara	DNAI	Stock Option (right to buy)	A - Award	D	6,58		82 500		82 500
2016-03-10	2016-03-08	4	Chapman Wendy	DNAI	Stock Option (right to buy)	A - Award	D	6,58		25 000		25 000
2016-03-10	2016-03-08	4	You Angie	DNAI	Stock Option (right to buy)	A - Award	D	6,58		75 000		75 000
2016-02-24	2016-02-22	4	Chapman Wendy	DNAI	Stock Option (right to buy)	M - Exercise	D	0,97		-3 000		79 248
2016-02-24	2016-02-22	4	Chapman Wendy	DNAI	Common Stock	S - Sale	D		7,0600	-3 000	-21		0
2016-02-24	2016-02-22	4	Chapman Wendy	DNAI	Common Stock	M - Exercise	D		0,9690	3 000	3		3 000
2016-01-25	2016-01-22	4	Chapman Wendy	DNAI	Stock Option (right to buy)	M - Exercise	D	0,97		-5 000		82 248
2016-01-25	2016-01-22	4	Chapman Wendy	DNAI	Common Stock	S - Sale	D		9,3946	-5 000	-47		0
2016-01-25	2016-01-22	4	Chapman Wendy	DNAI	Common Stock	M - Exercise	D		0,9690	5 000	5		5 000
2016-01-22	2016-01-22	4	Rodigueza Wendi	DNAI	Common Stock	S - Sale	D		9,6600	-1 000	-10		156 276
2016-01-22	2016-01-21	4	Rodigueza Wendi	DNAI	Common Stock	S - Sale	D		10,3230	-1 000	-10		157 276
2016-01-22	2016-01-20	4	Rodigueza Wendi	DNAI	Common Stock	S - Sale	D		9,5900	-1 000	-10		158 276
2016-01-19	2016-01-15	4	Glover Nicholas	DNAI	Stock Option (right to buy)	M - Exercise	D	0,97		-5 000		864 219
2016-01-19	2016-01-15	4	Glover Nicholas	DNAI	Common Stock	S - Sale	D		10,0446	-5 000	-50		0
2016-01-19	2016-01-15	4	Glover Nicholas	DNAI	Common Stock	M - Exercise	D		0,9690	5 000	5		5 000
2016-01-14	2016-01-12	4	Lovejoy Chandra D	DNAI	Stock Option (right to buy)	M - Exercise	D	0,97		-7 551		46 140
2016-01-14	2016-01-12	4	Lovejoy Chandra D	DNAI	Common Stock	S - Sale	D		11,9282	-5 562	-66		0
2016-01-14	2016-01-12	4	Lovejoy Chandra D	DNAI	Common Stock	S - Sale	D		11,0628	-15 411	-170		5 562
2016-01-14	2016-01-12	4	Lovejoy Chandra D	DNAI	Common Stock	M - Exercise	D		0,9690	7 551	7		20 973
2015-12-02		3	Anderson Keith Edward	DNAI	No securities are beneficially owned		D						0
2015-12-02	2015-12-01	4	Anderson Keith Edward	DNAI	Stock Option (right to buy)	A - Award	D	18,33		100 000		100 000
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-287 631		0
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Series C Preferred Stock	C - Conversion	I			-471 242		0
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Series C Preferred Stock	F - Taxes	I			-38 824		471 242
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Series C Preferred Stock	X - Other	I			126 558		510 066
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Series C Preferred Stock Warrant (right to buy)	X - Other	I		5,2150	-126 558	-660	0
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Common Stock	J - Other	I		5,2150	39 889	208		798 762
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Common Stock	C - Conversion	I			287 631			758 873
2015-07-21	2015-07-21	4	Vitangcol Alvin By Capital Midwest Fund II, L.P.	DNAI	Common Stock	C - Conversion	I			471 242			471 242
2015-07-21	2015-07-21	4	Topper James N By Frazier Healthcare VI, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-1 869 606		0
2015-07-21	2015-07-21	4	Topper James N By Frazier Healthcare VI, L.P.	DNAI	Common Stock	P - Purchase	I		17,0000	220 000	3 740		2 186 195
2015-07-21	2015-07-21	4	Topper James N By Frazier Healthcare VI, L.P.	DNAI	Common Stock	J - Other	I		5,2150	96 589	504		1 966 195
2015-07-21	2015-07-21	4	Topper James N By Frazier Healthcare VI, L.P.	DNAI	Common Stock	C - Conversion	I			1 869 606			1 869 606
2015-07-21	2015-07-21	4	Thompson Peter A. See Footnotes	DNAI	Series D Preferred Stock	C - Conversion	I			-1 725 790		0
2015-07-21	2015-07-21	4	Thompson Peter A. See Footnotes	DNAI	Common Stock	P - Purchase	I		17,0000	175 000	2 975		1 989 949
2015-07-21	2015-07-21	4	Thompson Peter A. See Footnotes	DNAI	Common Stock	J - Other	I		5,2150	89 159	465		1 814 949
2015-07-21	2015-07-21	4	Thompson Peter A. See Footnotes	DNAI	Common Stock	C - Conversion	I			1 725 790			1 725 790
2015-07-21	2015-07-21	4	Rodigueza Wendi	DNAI	Series B-1 Preferred Stock	C - Conversion	D			-1 966		0
2015-07-21	2015-07-21	4	Rodigueza Wendi	DNAI	Common Stock	C - Conversion	D			1 966			159 276
2015-07-21	2015-07-21	4	Parfet Donald R By Palmero Group LLC	DNAI	Series C Preferred Stock	C - Conversion	I			-13 130		0
2015-07-21	2015-07-21	4	Parfet Donald R By Palmero Group LLC	DNAI	Series A Preferred Stock	C - Conversion	I			-46 034		0
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Series B-1 Preferred Stock	C - Conversion	I			-142 422		0
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Series B Preferred Stock	C - Conversion	I			-189 933		0
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Series A Preferred Stock	C - Conversion	I			-306		0
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Series C Preferred Stock	C - Conversion	I			-65 938		0
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Series B-1 Preferred Stock	C - Conversion	I			-121 242		0
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Series B Preferred Stock	C - Conversion	I			-23 944		0
2015-07-21	2015-07-21	4	Parfet Donald R By wife	DNAI	Series A Preferred Stock	C - Conversion	I			-4 415		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series C Preferred Stock	C - Conversion	I			-24 277		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series C Preferred Stock	F - Taxes	I			-221		24 277
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series C Preferred Stock	X - Other	I			719		24 498
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series C Preferred Stock Warrant (right to buy)	X - Other	I		5,2150	-719	-4	0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock	C - Conversion	I			-516 203		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock	F - Taxes	I			-2 941		516 203
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock	X - Other	I			6 711		519 144
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock Warrant (right to buy)	X - Other	I		7,4500	-6 711	-50	0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock	F - Taxes	I			-40 729		512 433
2015-07-21	2015-07-21	4	Parfet Donald R y Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock	X - Other	I			265 536		553 162
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B-1 Preferred Stock Warrant (right to buy)	X - Other	I		2,6080	-265 536	-693	0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series B Preferred Stock	C - Conversion	I			-153 485		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Series A Preferred Stock	C - Conversion	I			-26 728		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Series D Preferred Stock	C - Conversion	I			-11 505		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Series C Preferred Stock	C - Conversion	I			-59 225		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Series B-1 Preferred Stock	C - Conversion	I			-67 112		0
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Group, LLC	DNAI	Series A Preferred Stock	C - Conversion	I			-307		0
2015-07-21	2015-07-21	4	Parfet Donald R By Palmero Group LLC	DNAI	Common Stock	J - Other	I		5,2150	819	4		65 779
2015-07-21	2015-07-21	4	Parfet Donald R By Palmero Group LLC	DNAI	Common Stock	C - Conversion	I			13 130			64 960
2015-07-21	2015-07-21	4	Parfet Donald R By Palmero Group LLC	DNAI	Common Stock	C - Conversion	I			51 830			51 830
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	C - Conversion	I			142 422			353 802
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	C - Conversion	I			211 036			211 380
2015-07-21	2015-07-21	4	Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006	DNAI	Common Stock	C - Conversion	I			344			344
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Common Stock	J - Other	I		5,2150	4 119	21		217 903
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Common Stock	C - Conversion	I			65 938			213 784
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Common Stock	C - Conversion	I			121 242			147 846
2015-07-21	2015-07-21	4	Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006	DNAI	Common Stock	C - Conversion	I			26 604			26 604
2015-07-21	2015-07-21	4	Parfet Donald R By wife	DNAI	Common Stock	C - Conversion	I			4 970			4 970
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock	J - Other	I		5,2150	1 552	8		770 045
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock	C - Conversion	I			24 277			768 493
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock	C - Conversion	I			516 203			744 216
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock	C - Conversion	I			170 538			228 013
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock	C - Conversion	I			30 093			57 475
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Common Stock	J - Other	I		5,2150	4 413	23		142 255
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Common Stock	C - Conversion	I			11 505			137 842
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Common Stock	C - Conversion	I			59 225			126 337
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Ventures Annex Fund LP	DNAI	Common Stock	C - Conversion	I			67 112			67 112
2015-07-21	2015-07-21	4	Parfet Donald R By Apjohn Group, LLC	DNAI	Common Stock	C - Conversion	I			345			589
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-44 991		0
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-2 064 308		0
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	P - Purchase	I		17,0000	4 693	80		2 438 270
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	P - Purchase	I		17,0000	215 307	3 660		2 433 577
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	J - Other	I		5,2150	2 324	12		2 218 270
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	J - Other	I		5,2150	106 647	556		2 215 946
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	C - Conversion	I			44 991			2 109 299
2015-07-21	2015-07-21	4	VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	C - Conversion	I			2 064 308			2 064 308
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-44 991		0
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures Fund VII, L.P.	DNAI	Series D Preferred Stock	C - Conversion	I			-2 064 308		0
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	P - Purchase	I		17,0000	4 693	80		2 438 270
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	P - Purchase	I		17,0000	215 307	3 660		2 433 577
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	J - Other	I		5,2150	2 324	12		2 218 270
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	J - Other	I		5,2150	106 647	556		2 215 946
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P.	DNAI	Common Stock	C - Conversion	I			44 991			2 109 299
2015-07-21	2015-07-21	4	CHA ALBERT By Vivo Ventures Fund VII, L.P.	DNAI	Common Stock	C - Conversion	I			2 064 308			2 064 308
2015-07-21	2015-07-21	4	ORBIMED ADVISORS LLC See Footnotes	DNAI	Series D Preferred Stock	C - Conversion	I			-1 725 790		0
2015-07-21	2015-07-21	4	ORBIMED ADVISORS LLC See Footnotes	DNAI	Common Stock	P - Purchase	I		17,0000	175 000	2 975		1 989 949
2015-07-21	2015-07-21	4	ORBIMED ADVISORS LLC See Footnotes	DNAI	Common Stock	J - Other	I		5,2150	89 159	465		1 814 949
2015-07-21	2015-07-21	4	ORBIMED ADVISORS LLC See Footnotes	DNAI	Common Stock	C - Conversion	I			1 725 790			1 725 790
2015-07-15		3	You Angie	DNAI	Common Stock		D						206 504
2015-07-15		3	You Angie	DNAI	Common Stock		D						206 504
2015-07-15		3	Rodigueza Wendi	DNAI	Common Stock		D						314 620
2015-07-15		3	Rodigueza Wendi	DNAI	Common Stock		D						314 620
2015-07-15		3	Messmann Richard A	DNAI	Common Stock		D						80 104
2015-07-15		3	Messmann Richard A	DNAI	Common Stock		D						80 104
2015-07-15		3	Lovejoy Chandra D	DNAI	Common Stock		D						26 844
2015-07-15		3	Lovejoy Chandra D	DNAI	Common Stock		D						26 844
2015-07-15		3	Parfet Donald R By Apjohn Group, LLC	DNAI	Common Stock		I						97 718
2015-07-15		3	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock		I						124 856
2015-07-15		3	Parfet Donald R By Apjohn Ventures Fund, LP	DNAI	Common Stock		I						124 856
2015-07-15		3	Parfet Donald R By Apjohn Group, LLC	DNAI	Common Stock		I						97 718
2015-07-15		3	Parfet Donald R	DNAI	Common Stock		D						167 322
2015-07-15		3	Parfet Donald R	DNAI	Common Stock		D						167 322

Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych

Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych

Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)

Konwersja instrumentu pochodnego

Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki

Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki

Darowizna papierów wartościowych przez lub na rzecz insidera

Swapy kapitałowe i podobne transakcje zabezpieczające

Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)

Transakcja dobrowolnie zgłoszona na Formularzu 4

Inne (wraz z przypisem opisującym transakcję)

SRRA / Sierra Oncology Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5